Peer Review History
| Original SubmissionJanuary 5, 2025 |
|---|
|
Dear Dr. Song, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please, see reviewers comments to implement your manuscript. Moreover, it is important to improve some aspects of the article. Specifically: While the article presents a strong viewpoint, a more balanced discussion including counterarguments or limitations would strengthen its academic rigor. Please submit your revised manuscript by Jul 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Andrea Cioffi Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating in your Funding Statement: [This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2022R1C1C1011730).]. Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes Reviewer #4: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: I Don't Know Reviewer #2: I Don't Know Reviewer #3: Yes Reviewer #4: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #1: The article is a well-executed and timely study that makes significant contributions to understanding medical abortion discourse in South Korea and the US. However, addressing the outlined limitations and integrating more diverse data and methods could enhance the depth, applicability, and impact of the findings. Main concerns: 1) The reliance on web-scraped news articles from specific platforms like Naver News and Google News may introduce a selection bias, potentially excluding diverse or less mainstream perspectives. 2) The dataset includes articles from 2006 to 2022, which may overlook temporal shifts in discourse, especially after pivotal legal or policy changes. 3) While the study attempts to adapt sentiment analysis tools for Korean and English texts, the effectiveness of these tools in capturing cultural nuances and contextual meanings remains unclear. Misinterpretation of sentiments could affect the validity of the results. 4) The exclusive focus on news articles neglects other influential media forms, such as social media or public opinion surveys, which might provide a broader understanding of societal attitudes. Reviewer #2: Dear Authors, I read with great interest your article on abortion. This study will use AI-driven text analysis (topic modeling and sentiment analysis) to examine and compare how abortion with mifepristone is discussed in South Korea and the US. It will analyze social issues, legal debates, cultural attitudes, and public sentiment surrounding medical abortion, offering insights into how the discourse varies across different legal, ethical, and cultural landscapes. My concern is that if there is no human input to choose which articles to be included in the analysis, then it may mean that you are including everything which may not reflect the actual social, cultural and legal attitudes. google and other sites are full of non-sense information. I am not sure if we can draw any valuable conclusions if we are not fully aware of what we are analysing. Reviewer #3: General Comment I sincerely believe this is an excellent piece of work, carefully designed, well-executed, and meaningful in its scope and contribution. Abstract The abstract serves as the gateway and first impression of the manuscript. I recommend that you make it more comprehensive and inclusive, offering a clear overview of the study's objectives, methods, key findings, and conclusions. This will help readers grasp the essence of your work at a glance. Background Well done. However, to strengthen this section, I suggest expanding on the research problem and the significance of the study. Additionally, it would be valuable to discuss the global use and prevalence of mifepristone. Including relevant data from the World Health Organization (WHO) could provide useful context and reinforce the importance of your research. Methods • This section would benefit from a more detailed explanation of the platform selection process for data extraction. Please clarify the steps and procedures followed, including the criteria for inclusion and exclusion of data sources. • Furthermore, a brief but clear description of your measurement procedures would enhance the methodological transparency of the study. Results and Discussion You have effectively presented and interpreted your findings. The analysis is insightful and well-connected to the research questions. This section is a strength of the manuscript. Well done. Conclusion Since this is the final impression of your work, I suggest refining it slightly. Highlight the key findings, emphasize their wider relevance, and reinforce the significance of the study. A strong conclusion provides a sense of closure and impact for the reader. References Some references appear not to fully align with the journal’s formatting guidelines. Please ensure that all citations strictly follow the required style. Reviewer #4: I would like to thank the authors for the opportunity to review this manuscript. The study presents an interesting comparative analysis of media discourse surrounding mifepristone and medical abortion in South Korea and the United States using text mining techniques. However, there are several areas that would benefit from revision 1- In the introduction: what are the specific gaps in knowledge that this study aims to address. And why these two countries? 2- The data collection process lacks transparency regarding the search terms used for web crawling. The authors mention using Google News and Naver News but do not specify the exact search queries employed 3- The authors should provide more information about the criteria used for including or excluding news articles. Was there any screening process to ensure the articles were specifically focused on mifepristone rather than abortion more broadly? 4- The significant disparity in sample size between Korean (7,938) and US (650) articles raises concerns about comparability. The authors should address how this imbalance might affect the interpretation of results and whether any normalization techniques were applied to account for this difference. 5- Figure 1 (Pipeline of the text analysis) is referenced but not adequately described in the text. 6- grammatical errors and awkward phrasings throughout the manuscript; e.g: - line 41: "including and is extensively prescribed" → delete "including." - Line 68: "Comparative analyses of news content between countries can provide" → "Comparative analyses of news content can provide." - Page 1, Abstract: "distinct pattern" should be "distinct patterns". 7- The abbreviations should be defined at first use and then used consistently throughout the manuscript. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Nourah Hasan Al Qahtani Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Song, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We note that some of the comments of the reviewers refer to specific articles for you to cite. Please note that it is not mandatory that you cite these specific articles and you are welcome to seek alternatives manuscripts in the literature that are relevant to your manuscript’s content. Please submit your revised manuscript by Nov 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Andrea Cioffi Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed Reviewer #5: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #3: Yes Reviewer #5: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #3: Yes Reviewer #5: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #3: Yes Reviewer #5: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #3: Yes Reviewer #5: Yes ********** Reviewer #1: The revised manuscript effectively addresses the prior concerns and now presents a well-structured, ethically sensitive, and scientifically sound analysis with just minor refinements as noted below: 1.Ethical Clarity: You mention ethics approval and waiver of consent, but do not explicitly state how sensitive abortion data were handled (e.g., anonymisation, database separation, encryption). 2.Cultural Context (Discussion section): A brief acknowledgement that the findings may not be generalizable to settings where abortion is legally restricted or stigmatised would enhance the discussion’s depth. 3.Clinical Significance: The adjusted odds ratios for biochemical pregnancy and clinical pregnancy are slightly reduced but not statistically significant. Consider adding a sentence to discuss whether this might still be clinically meaningful or merits further investigation in a larger cohort. Reviewer #3: All comments and suggestions have been adequately addressed. The authors have made significant improvements, and I believe the work is now ready for acceptance. Reviewer #5: I would like to sincerely thank the Editor for the opportunity to review a manuscript submitted to such a highly esteemed journal. It is an honour for me. It has been a pleasure to read this article, which I found to be well-structured and highly original in both its methodological approach and thematic focus. Nevertheless, I believe that some revisions are necessary before the manuscript can be recommended for publication. I hope that the following suggestions will support the authors in strengthening their work and guiding their revisions. - The Introduction is solid, well-documented, and clearly structured, with a strong rationale for the study. However, improvements in language style, clarity, and conciseness would enhance the manuscript’s readability and impact, particularly for an international audience. Additionally, several grammatical issues require attention before publication. For instance, the phrase “in South Korean” should be corrected to “in South Korea,” and expressions such as “concerns persist safety of mifepristone” are grammatically problematic. Terms such as “medial abortion” also need revision for accuracy. Moreover, the legal and regulatory references appear somewhat imbalanced: while the US context is discussed in detail, the Korean legal framework receives more limited attention. A more thorough and globally contextualized background would be beneficial. In particular, integrating European examples would offer a more comprehensive overview of international approaches to medical abortion—especially since the conclusions highlight global policy implications. To that end, I recommend including references such as: https://pubmed.ncbi.nlm.nih.gov/34897104/ https://pubmed.ncbi.nlm.nih.gov/12831608/ https://pubmed.ncbi.nlm.nih.gov/12137129/ These sources can enrich the comparative dimension of the analysis and support a more robust global framing. - The Methods section is clearly structured and methodologically sound. However, unless I have overlooked it, the initial number of articles retrieved per country (prior to filtering or selection) is not explicitly stated—this detail would improve transparency. Additionally, I would suggest adding a brief note regarding the reproducibility of the research process (e.g., availability of code, corpora, or full protocol), which is particularly important in computational text analysis. - The Results are presented in a clear and orderly manner, and the comparative analysis between South Korea and the US is effective. To further support interpretation, I suggest including a short summary section that explicitly highlights the key differences observed between the two countries in terms of themes and sentiments. - In the Discussion, two aspects warrant careful attention: Avoid implying causal relationships that are not empirically grounded. For example, the assumption that illegal online trade results directly from regulatory restrictions should be carefully qualified as a possible causal link or interpretative hypothesis, unless further evidence is provided. The influence of media narratives on public opinion is mentioned but not sufficiently explored. A brief reflection on how and why media framing can shape public understanding—supported by relevant literature—would add theoretical depth and policy relevance to the discussion. - The Conclusion successfully summarizes the findings but remains rather general. It would benefit from being more precise and action-oriented, particularly by offering concrete recommendations. For example, the authors could suggest how media coverage might adopt a more balanced and informative narrative regarding medical abortion, or how policymakers might engage with media discourses more strategically. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: JACKLINE AKELLO Reviewer #3: No Reviewer #5: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Dear Dr. Song, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 26 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Andrea Cioffi Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Please note that it is very important to submit a manuscript with all the changes highlighted. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #5: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #5: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #5: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #5: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #5: Yes ********** Reviewer #5: I would like to thank the Editor once again for the opportunity to review this manuscript. However, I am unable to clearly identify the revisions made in response to my previous comments. Although the authors provide a point-by-point reply, these responses do not always appear to correspond in a clear and consistent manner to changes in the main text. I would therefore kindly ask the authors to submit a newly revised version of the manuscript, in clean format, in which only the additions, modifications, and new references introduced in response to the previous review are clearly highlighted—for example, marked in red—so as to allow a more accurate assessment of the adequacy of the revisions undertaken. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #5: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 3 |
|
Comparative analysis of social issues toward medical abortion using mifepristone in South Korea and the US: Topic modelling and sentiment analysis PONE-D-25-00622R3 Dear Dr. Song, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Andrea Cioffi Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #5: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #5: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #5: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #5: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #5: Yes ********** Reviewer #5: Thank you to the Editor for the opportunity to review the manuscript again. The authors have carefully addressed my revision suggestions and implemented the requested changes. Overall, in its current form, the paper has improved substantially and, in my view, could be considered suitable for publication. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #5: No ********** |
| Formally Accepted |
|
PONE-D-25-00622R3 PLOS One Dear Dr. Song, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Andrea Cioffi Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .